Clinical Trial Update: Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rapamycin-eluting stents with paclitaxel-eluting balloons for in-stent restenosis; status of the trial is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• Paclitaxel-eluting balloon catheter (paclitaxel)
• Rapamycin-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Medical University of Warsaw | Conditions: In-Stent Restenosis | Phase 3 | Status: UNKNOWN